Logo
x

Search

Subscribe Now

Accelerate

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

  • February 25, 2021
Sarepta Therapeutics Collaborates with University of Florida to Accelerate the Development of Therapies for Rare Genetic Diseases

Sarepta Therapeutics Collaborates with University of Florida to Accelerate the Development of Therapies for Rare Genetic Diseases

  • August 12, 2020
Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndrome

Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndro...

  • July 23, 2020
Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases

Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases

  • June 25, 2020
Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19

Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19

  • April 24, 2020
Blackstone and Alnylam Enter into a Collaboration to Accelerate the Advancement of RNAi Therapeutics

Blackstone and Alnylam Enter into a Collaboration to Accelerate the Advancement of RNAi Therapeutics

  • April 14, 2020
AbbVie Seeks the US FDA’s Accelerated Approval of Telisotuzumab Vedotin (Teliso-V) for Treating Non-Squamous NSCLC

    AbbVie Seeks the US FDA’s Accelerated Approval of Telisotuzumab Vedotin (Teliso-V) for Treating Non-Squamous NSCLC

    • September 30, 2024
    Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full Approval for Treating IgA Nephropathy

      Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full Approval for Treating IgA Nephropathy

      • September 6, 2024
      US FDA Grants Accelerated Approval to Gilead’s Livdelzi (Seladelpar) to Treat Primary Biliary Cholangitis (PBC)

        US FDA Grants Accelerated Approval to Gilead’s Livdelzi (Seladelpar) to Treat Primary Biliary Cholangitis (PBC)

        • August 16, 2024
        Novartis Reports the US FDA’s Accelerated Approval of Fabhalta to Treat Primary IgA Nephropathy (IgAN)

          Novartis Reports the US FDA’s Accelerated Approval of Fabhalta to Treat Primary IgA Nephropathy (IgAN)

          • August 9, 2024
          Adaptimmune’s Tecelra Gains the US FDA’s Accelerated Approval to Treat Synovial Sarcoma

            Adaptimmune’s Tecelra Gains the US FDA’s Accelerated Approval to Treat Synovial Sarcoma

            • August 5, 2024
            Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis

              Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis

              • July 3, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.